Picture of Fulgent Genetics logo

FLGT — Fulgent Genetics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Brief: Fulgent Genetics Reports Q4 2020 Financial Results

March 4 (Reuters) - Fulgent Genetics Inc  FLGT.O :
    * Q4 NON-GAAP EARNINGS PER SHARE $6.20
    * Q4 GAAP EARNINGS PER SHARE $6.16
    * Q4 REVENUE $295 MILLION
    * SEES Q1 REVENUE AT LEAST $325 MILLION
    * SEES FY 2021 REVENUE UP 90 PERCENT
    * SEES FY 2021 REVENUE ABOUT $800 MILLION
    * Q4 REVENUE ESTIMATE $199.4 MILLION -- REFINITIV IBES DATA
    * Q4 EARNINGS PER SHARE ESTIMATE $4.05 -- REFINITIV IBES
DATA
    * EXPECTS GAAP INCOME OF ABOUT $12.00 PER SHARE; NON-GAAP
INCOME
OF ABOUT $12.50 PER SHARE IN 2021
    * FY2021 EARNINGS PER SHARE VIEW $11.55, REVENUE VIEW $600.2
MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX3M70Fj 
Further company coverage:  FLGT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Fulgent Genetics

See all news